Zurcher Kantonalbank (Zurich Cantonalbank) Biomarin Pharmaceutical Inc Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $34.1 Billion
- Q4 2024
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 198,756 shares of BMRN stock, worth $14.3 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
198,756
Previous 96,962
104.98%
Holding current value
$14.3 Million
Previous $6.82 Million
91.69%
% of portfolio
0.04%
Previous 0.02%
Shares
27 transactions
Others Institutions Holding BMRN
# of Institutions
626Shares Held
183MCall Options Held
2MPut Options Held
1.67M-
Black Rock Inc. New York, NY22.7MShares$1.64 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.4MShares$1.4 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.2MShares$1.31 Billion0.94% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$1.06 Billion0.61% of portfolio
-
Capital Research Global Investors Los Angeles, CA13MShares$936 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $13.4B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...